Projects per year
Personal profile
Research interests
- Exploring and understanding the key pathways involved in the development and progression of diabetic complications.
- Development of new therapeutics targeted towards the prevention and management of diabetic complications.
Research goals
The Biochemistry of Diabetes Complications Laboratory addresses important mechanistic questions across the spectrum of diabetic complications. This work is directed towards the development of novel preventive, diagnostic and therapeutic strategies through multidisciplinary approaches combining bench-top research with human physiology and clinical studies. Our work directly impacts on patient care and has been published in major journals including Circulation Research, Diabetes, Diabetes Care and Diabetologia.
Professor Merlin Thomas is an internationally recognised clinician-scientist working in the field of diabetic complications, an area of utmost importance for the health of Australians. He is trained in both nephrology and endocrinology, but is also a state-of-the-art molecular scientist. Globally, he is the third-highest ranked expert in diabetic kidney disease and recognised as an opinion leader in the field of diabetic complications. His translational research spans basic biochemistry and biology to epidemiology and clinical trials. Dr Thomas has an exceptional track record of productivity with more than 270 publications many in the highest ranked journals in his field. He is also a sought-after speaker, teacher and best-selling author, demonstrating his exceptional capability to communicate complex scientific understanding to a general audience.
As both a clinician and a scientist, Professor Thomas’ work is keenly focused on the application of his work, improving the understanding and management of diabetic complications. This work has led to the establishment of international patents as well as influencing national and international guidelines. He is CIB in the newly created NHMRC Diabetes Complications CRE. His “Biochemistry of Diabetes Complications” laboratory in the newly created Department of Diabetes at Monash University is an ideal environment for multidisciplinary research, providing a combination of intellectual and scientific expertise, high-quality infrastructure and state-of-the-art capabilities.
The principal objective of Professor Thomas' research laboratory is to advance the field of diabetes by identifying and validating novel targets towards the development of efficacious strategies for the prevention and management of diabetic complications.
Research area keywords
- Diabetes
- Advanced Glycation End-products (AGEs)
- Atherosclerosis
- Chronic Kidney Disease (CKD)
- Diabetic Complications
- Diabetic Kidney Disease (DKD)
- Renin Angiotensin System
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Augmenting the activity of glyoxalase-1 to increase dicarbonyl clearance
1/01/20 → 31/12/22
Project: Research
Transactivation of RAGE as a novel therapeutic target in diabetes
1/01/19 → 31/12/20
Project: Research
Modulating Pathogenic Signalling Towards the Prevention of Diabetic Complications
1/01/17 → 31/12/20
Project: Research
Identifying the epigenomic fingerprint of coronary heart disease in Chinese adults with type 2 diabetes
El-Osta, S., Huang, Y., Chan, J. C. N., Thomas, M. & Cooper, M.
1/01/16 → 31/12/20
Project: Research
Transactivation of RAGE: a novel therapeutic target in type 1 diabetes
Thomas, M., Baell, J., Rosado, C. & Dimitropoulos, A.
1/10/18 → 31/03/20
Project: Research
Research Output
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Reutens, A. T., Jandeleit-Dahm, K., Thomas, M., Salim, A., De Livera, A. M., Bach, L. A., Colman, P. G., Davis, T. M. E., Ekinci, E. I., Fulcher, G., Hamblin, P. S., Kotowicz, M. A., MacIsaac, R. J., Morbey, C., Simmons, D., Soldatos, G., Wittert, G., Wu, T., Cooper, M. E. & Shaw, J. E., Mar 2020, In : Contemporary Clinical Trials. 90, 8 p., 105892.Research output: Contribution to journal › Article › Other › peer-review
The Heart Failure with Preserved Ejection Fraction Conundrum—Redefining the Problem and Finding Common Ground?
Iyngkaran, P., Thomas, M. C., Neil, C., Jelinek, M., Cooper, M., Horowitz, J. D., Hare, D. L. & Kaye, D. M., 1 Apr 2020, In : Current Heart Failure Reports. 17, 2, p. 34-42 9 p.Research output: Contribution to journal › Review Article › Research › peer-review
The Long-Term Incidence of Hospitalization for Ketoacidosis in Adults with Established T1D-A Prospective Cohort Study
Thomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., Groop, P. H. & On Behalf of the FinnDiane Study Group, 1 Jan 2020, In : Journal of Clinical Endocrinology and Metablism. 105, 1, p. 231-241 11 p.Research output: Contribution to journal › Article › Research › peer-review
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: Novel therapeutic target?
Garg, M., Royce, S. G., Tikellis, C., Shallue, C., Batu, D., Velkoska, E., Burrell, L. M., Patel, S. K., Beswick, L., Jackson, A., Britto, K., Lukies, M., Sluka, P., Wardan, H., Hirokawa, Y., Tan, C. W., Faux, M., Burgess, A. W., Hosking, P., Monagle, S. & 3 others, , 13 Aug 2019, (Accepted/In press) In : Gut. 11 p.Research output: Contribution to journal › Article › Research › peer-review
Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?
Iyngkaran, P., Noaman, S., Chan, W., Mahadavan, G., Thomas, M. C. & Rajendran, S., 1 Aug 2019, In : Current Cardiology Reports. 21, 8, 10 p., 87.Research output: Contribution to journal › Review Article › Research › peer-review
1
Citation
(Scopus)